Press release
11.11.2022 To the attention of interested persons EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors […]
Press release
11.11.2022 To the attention of interested persons EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines download document …
Press release
10.11.2022 To the attention of interested persons EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine download […]
Important notification
07.11.2022 To the attention of authorised representatives, manufacturers, economic operators and all stakeholders Please be informed that on 31 October […]
Important notification
31.10.2022 To the attention of manufacturers of in vitro diagnostic medical devices, economic operators, notified bodies and all stakeholders Please […]
Press release
28.10.2022 To the attention of interested persons EMA recommends measures to minimise risk of serious side effects with Janus kinase […]
Press release
28.10.2022 To the attention of interested persons EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines download document …
Important notification
14.10.2022 To the attention of medical devices manufacturers and all stakeholders On 13.10.2022, Emergency ordinance regarding the setup of an […]
Important notification
10.10.2022 To the attention of manufacturers of custom-made devices, based in Romania Please be informed that Order No. 2845 of […]
Press release
30.09.2022 To the attention of interested persons New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome download document […]